Studies related to Symptoms of Bipolar Disorder and CDP-choline

A Randomized, Placebo-controlled Trial Of Citicoline Add-on Therapy In Outpatients With Bipolar Disorder And Cocaine Dependence

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 44
Gender Both Genders
Age Range 18-29, 30-44
Body Types Average
Notes for this study:
In persons with cocaine dependence and bipolar disorder, supplementation of CDP-choline has failed to influence symptoms of bipolar disorder (mania and depression) but was associated with reduced occurrence of cocaine positive urine at the end of the trial (when the patients were directed to not consume cocaine).